Cargando…

Nose-to-brain drug delivery approach: a key to easily accessing the brain for the treatment of Alzheimer's disease

Detalles Bibliográficos
Autores principales:	Alexander, Amit, Saraf, Shailendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199953/ https://www.ncbi.nlm.nih.gov/pubmed/30323136 http://dx.doi.org/10.4103/1673-5374.241458

Ejemplares similares

Nanoemulsions for “Nose-to-Brain” Drug Delivery
por: Bonferoni, Maria Cristina, et al.
Publicado: (2019)

Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier
por: Lee, David, et al.
Publicado: (2021)

Nose-to-Brain Delivery
por: Giunchedi, Paolo, et al.
Publicado: (2020)

Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS
por: Sarma, Anupam, et al.
Publicado: (2020)

Microemulsion-Based Media in Nose-to-Brain Drug Delivery
por: Froelich, Anna, et al.
Publicado: (2021)

Non-Invasive Strategies for Nose-to-Brain Drug Delivery
por: Trevino, JT, et al.
Publicado: (2020)

Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases
por: Montegiove, Nicolò, et al.
Publicado: (2022)

Lomustine’s nanoemulsion as nose-to-brain drug delivery system for CNS tumor treatment
por: Alaayedi, Maryam H., et al.
Publicado: (2023)

Nanoemulsion based Intranasal Delivery of Antimigraine Drugs for Nose to Brain Targeting
por: Bhanushali, R. S., et al.
Publicado: (2009)

Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders
por: Boyuklieva, Radka, et al.
Publicado: (2022)

Computational, In Vitro, and In Vivo Models for Nose-to-Brain Drug Delivery Studies
por: Boyuklieva, Radka, et al.
Publicado: (2023)

The Potential of the Nose-to-Brain Delivery of PACAP for the Treatment of Neuronal Disease
por: Cherait, Asma, et al.
Publicado: (2023)

Brain ischemia as a bridge to Alzheimer’s disease
por: Pluta, Ryszard
Publicado: (2021)

Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels
por: Cunha, Sara, et al.
Publicado: (2021)

Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
por: Mannu, Piero, et al.
Publicado: (2011)

A non-invasive direct nose to brain drug delivery platform vs. invasive brain delivery approach: patient-centered care impact analysis
por: Kobo-Greenhut, Ayala, et al.
Publicado: (2022)

Nose-to-Brain Delivery of Antiviral Drugs: A Way to Overcome Their Active Efflux?
por: Dalpiaz, Alessandro, et al.
Publicado: (2018)

Cell-Penetrating Peptides as Valuable Tools for Nose-to-Brain Delivery of Biological Drugs
por: De Martini, Lisa Benedetta, et al.
Publicado: (2023)

Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders
por: Awad, Rania, et al.
Publicado: (2023)

Drugs, sleep, and the addicted brain
por: Valentino, Rita J., et al.
Publicado: (2019)

Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer’s disease?
por: Petrovskaya, Aleksandra, et al.
Publicado: (2023)

In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases
por: Aderibigbe, Blessing Atim
Publicado: (2018)

Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease
por: Tao, Qing-Qing, et al.
Publicado: (2022)

Lipid and Polymeric Nanoparticles: Successful Strategies for Nose-to-Brain Drug Delivery in the Treatment of Depression and Anxiety Disorders
por: Alberto, Margarida, et al.
Publicado: (2022)

Formulation Strategies to Improve Nose-to-Brain Delivery of Donepezil
por: Espinoza, Lupe Carolina, et al.
Publicado: (2019)

Cachexia: Pathophysiology and Ghrelin Liposomes for Nose-to-Brain Delivery
por: T. de Barros, Cecilia, et al.
Publicado: (2020)

Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols
por: Alabsi, Wafaa, et al.
Publicado: (2022)

Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery
por: Pardridge, William M.
Publicado: (2020)

ADAM17/TACE: a key molecule in brain injury regeneration
por: Domínguez-García, Samuel, et al.
Publicado: (2019)

The brain and its time: intrinsic neural timescales are key for input processing
por: Golesorkhi, Mehrshad, et al.
Publicado: (2021)

Carbon Nanotropes: A Contemporary Paradigm in Drug Delivery
por: Tripathi, Avinash C., et al.
Publicado: (2015)

Shifting balance from neurodegeneration to regeneration of the brain: a novel therapeutic approach to Alzheimer's disease and related neurodegenerative conditions
por: Iqbal, Khalid, et al.
Publicado: (2014)

Defective autophagy and Alzheimer’s disease: is calcium the key?
por: Filadi, Riccardo, et al.
Publicado: (2019)

In Vitro Evaluation of Nasal Aerosol Depositions: An Insight for Direct Nose to Brain Drug Delivery
por: Maaz, Aida, et al.
Publicado: (2021)

The Upper Nasal Space: Option for Systemic Drug Delivery, Mucosal Vaccines and “Nose-to-Brain”
por: Shrewsbury, Stephen B.
Publicado: (2023)

Brain network modulation in Alzheimer’s disease: clinical phenotypes and windows of opportunity
por: Pini, Lorenzo
Publicado: (2022)

Multiple neuropathologies and dementia in the aging brain: A key role for cerebrovascular disease?
por: Charidimou, Andreas, et al.
Publicado: (2016)

Approaches to vascularizing human brain organoids
por: Ye, Bing
Publicado: (2023)

Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia
por: Salade, Laurent, et al.
Publicado: (2017)

The brain compensatory mechanisms and Alzheimer's disease progression: a new protective strategy
por: Bobkova, Natalia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i7a8u2vnskl8va6nsleu3j60nt